CSCI

(redirected from Continuous Subcutaneous Infusion)
Category filter:
AcronymDefinition
CSCIComputer Science
CSCICommission for Social Care Inspection (UK)
CSCICustomer Satisfaction and Continuous Improvement (Charles Industries, Ltd.)
CSCICircuit Switching Capable Interface
CSCIChannel Switching Capable Interface
CSCIClient Server Communications Interface
CSCIClimate Savers Computing Initiative
CSCIChartered Scientist (UK)
CSCIComputer Software Configuration Item
CSCIChina Small Cap Index
CSCICanadian Society for Clinical Investigation
CSCIContinuous Subcutaneous Infusion
CSCICommercial Satellite Communications Initiative
CSCICorticosterone Side-Chain Isomerase
CSCIComputer System Configuration Item
CSCICentre for the Study of Curriculum and Instruction (University of British Columbia, Vancouver)
CSCIComputer Software Component Interface
CSCICreative Solutions Consulting, Inc. (Indianapolis, IN)
CSCICortical Type of Striatocapsular Infarction (stroke syndrome)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Under the company's iNDiGO trial that is anticipated to conclude in 2017, the patients will be randomised to receive either continuous subcutaneous infusion of ND0612L or a placebo replaced every 24 hours during the 16-week treatment period.
Remodulin may be administered as a continuous subcutaneous infusion or continuous intravenous infusion; however, because of the risks associated with chronic indwelling central venous catheters, including serious blood stream infections, continuous intravenous infusion should be reserved for patients who are intolerant of the subcutaneous route, or in whom these risks are considered warranted.
Remodulin is already cleared in most European countries for the continuous subcutaneous infusion treatment of idiopathic or heritable PAH to improve exercise tolerance and symptoms in patients classified as New York Heart Association (NYHA) functional class III.
The advantages of continuous subcutaneous infusion of insulin analogs in critically ill patients are to be determined.
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension.
In the planned clinical trial, cenderitide will be delivered to heart failure patients for up to 24 hours through continuous subcutaneous infusion. Nile said it expects to complete the trial by the first quarter of 2012.
"We also expect to hear stakeholder feedback on whether certain insulin products--for example, those that use insulin pumps for continuous subcutaneous infusion among the approved uses--raise unique scientific considerations that we should be considering when evaluating biosimilar or interchangeable insulin products.
Full browser ?